UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G/A
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)*
LIPOCINE INC.
(Name of Issuer)
COMMON STOCK
(Title of Class of Securities)
53630X104
(CUSIP Number)
December 31, 2015
(Date of Event Which Requires Filing of This Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
* | The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. |
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP No. 53630X104 | Page 2 of 16 |
| | | | | |
1. | | Name of Reporting Persons Venrock Healthcare Capital Partners, L.P. |
2. | | Check the Appropriate Box if a Member of a Group (See Instructions) (a) x1 (b) ¨ |
3. | | SEC USE ONLY |
4. | | Citizenship or Place of Organization Delaware |
Number of Shares Beneficially Owned by Each Reporting Person With: | 5. | | Sole Voting Power 0 |
6. | | Shared Voting Power 1,269,9212 |
7. | | Sole Dispositive Power 0 |
8. | | Shared Dispositive Power 1,269,9212 |
9. | | Aggregate Amount Beneficially Owned by Each Reporting Person 1,269,9212 |
10. | | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨ |
11. | | Percent of Class Represented by Amount in Row (9) 7.0%3 |
12. | | Type of Reporting Person (See Instructions) PN |
1 | Venrock Healthcare Capital Partners, L.P., VHCP Co-Investment Holdings, LLC, Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management, LLC, VHCP Management II, LLC, Bong Koh and Anders Hove are members of a group for the purposes of this Schedule 13G/A. |
2 | Consists of 718,490 shares owned by Venrock Healthcare Capital Partners, L.P., 131,431 shares owned by VHCP Co-Investment Holdings, LLC, 298,846 shares owned by Venrock Healthcare Capital Partners II, L.P. and 121,154 shares owned by VHCP Co-Investment Holdings II, LLC. |
3 | This percentage is calculated based upon 18,253,456 shares of the Issuer’s common stock outstanding as of November 11, 2015, as set forth in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2015. |
CUSIP No. 53630X104 | Page 3 of 16 |
| | | | | |
1. | | Name of Reporting Persons VHCP Co-Investment Holdings, LLC |
2. | | Check the Appropriate Box if a Member of a Group (See Instructions) (a) x1 (b) ¨ |
3. | | SEC USE ONLY |
4. | | Citizenship or Place of Organization Delaware |
Number of Shares Beneficially Owned by Each Reporting Person With: | 5. | | Sole Voting Power 0 |
6. | | Shared Voting Power 1,269,9212 |
7. | | Sole Dispositive Power 0 |
8. | | Shared Dispositive Power 1,269,9212 |
9. | | Aggregate Amount Beneficially Owned by Each Reporting Person 1,269,9212 |
10. | | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨ |
11. | | Percent of Class Represented by Amount in Row (9) 7.0%3 |
12. | | Type of Reporting Person (See Instructions) OO |
1 | Venrock Healthcare Capital Partners, L.P., VHCP Co-Investment Holdings, LLC, Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management, LLC, VHCP Management II, LLC, Bong Koh and Anders Hove are members of a group for the purposes of this Schedule 13G/A. |
2 | Consists of 718,490 shares owned by Venrock Healthcare Capital Partners, L.P., 131,431 shares owned by VHCP Co-Investment Holdings, LLC, 298,846 shares owned by Venrock Healthcare Capital Partners II, L.P. and 121,154 shares owned by VHCP Co-Investment Holdings II, LLC. |
3 | This percentage is calculated based upon 18,253,456 shares of the Issuer’s common stock outstanding as of November 11, 2015, as set forth in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2015. |
CUSIP No. 53630X104 | Page 4 of 16 |
| | | | | |
1. | | Name of reporting persons Venrock Healthcare Capital Partners II, L.P. |
2. | | Check the appropriate box if a member of a group (see instructions) (a) x1 (b) ¨ |
3. | | SEC use only |
4. | | Citizenship or place of organization Delaware |
Number of shares beneficially owned by each reporting person with: | 5. | | Sole voting power 0 |
6. | | Shared voting power 1,269,9212 |
7. | | Sole dispositive power 0 |
8. | | Shared dispositive power 1,269,9212 |
9. | | Aggregate amount beneficially owned by each reporting person 1,269,9212 |
10. | | Check if the aggregate amount in Row (9) excludes certain shares (see instructions) ¨ |
11. | | Percent of class represented by amount in Row (9) 7.0%3 |
12. | | Type of reporting person (see instructions) PN |
1 | Venrock Healthcare Capital Partners, L.P., VHCP Co-Investment Holdings, LLC, Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management, LLC, VHCP Management II, LLC, Bong Koh and Anders Hove are members of a group for the purposes of this Schedule 13G/A. |
2 | Consists of 718,490 shares owned by Venrock Healthcare Capital Partners, L.P., 131,431 shares owned by VHCP Co-Investment Holdings, LLC, 298,846 shares owned by Venrock Healthcare Capital Partners II, L.P. and 121,154 shares owned by VHCP Co-Investment Holdings II, LLC. |
3 | This percentage is calculated based upon 18,253,456 shares of the Issuer’s common stock outstanding as of November 11, 2015, as set forth in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2015. |
CUSIP No. 53630X104 | Page 5 of 16 |
| | | | | |
1. | | Name of reporting persons VHCP Co-Investment Holdings II, LLC |
2. | | Check the appropriate box if a member of a group (see instructions) (a) x1 (b) ¨ |
3. | | SEC use only |
4. | | Citizenship or place of organization Delaware |
Number of shares beneficially owned by each reporting person with: | 5. | | Sole voting power 0 |
6. | | Shared voting power 1,269,9212 |
7. | | Sole dispositive power 0 |
8. | | Shared dispositive power 1,269,9212 |
9. | | Aggregate amount beneficially owned by each reporting person 1,269,9212 |
10. | | Check if the aggregate amount in Row (9) excludes certain shares (see instructions) ¨ |
11. | | Percent of class represented by amount in Row (9) 7.0%3 |
12. | | Type of reporting person (see instructions) OO |
1 | Venrock Healthcare Capital Partners, L.P., VHCP Co-Investment Holdings, LLC, Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management, LLC, VHCP Management II, LLC, Bong Koh and Anders Hove are members of a group for the purposes of this Schedule 13G/A. |
2 | Consists of 718,490 shares owned by Venrock Healthcare Capital Partners, L.P., 131,431 shares owned by VHCP Co-Investment Holdings, LLC, 298,846 shares owned by Venrock Healthcare Capital Partners II, L.P. and 121,154 shares owned by VHCP Co-Investment Holdings II, LLC. |
3 | This percentage is calculated based upon 18,253,456 shares of the Issuer’s common stock outstanding as of November 11, 2015, as set forth in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2015. |
CUSIP No. 53630X104 | Page 6 of 16 |
| | | | | |
1. | | Name of Reporting Persons VHCP Management, LLC |
2. | | Check the Appropriate Box if a Member of a Group (See Instructions) (a) x1 (b) ¨ |
3. | | SEC USE ONLY |
4. | | Citizenship or Place of Organization Delaware |
Number of Shares Beneficially Owned by Each Reporting Person With: | 5. | | Sole Voting Power 0 |
6. | | Shared Voting Power 1,269,9212 |
7. | | Sole Dispositive Power 0 |
8. | | Shared Dispositive Power 1,269,9212 |
9. | | Aggregate Amount Beneficially Owned by Each Reporting Person 1,269,9212 |
10. | | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨ |
11. | | Percent of Class Represented by Amount in Row (9) 7.0%3 |
12. | | Type of Reporting Person (See Instructions) OO |
1 | Venrock Healthcare Capital Partners, L.P., VHCP Co-Investment Holdings, LLC, Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management, LLC, VHCP Management II, LLC, Bong Koh and Anders Hove are members of a group for the purposes of this Schedule 13G/A. |
2 | Consists of 718,490 shares owned by Venrock Healthcare Capital Partners, L.P., 131,431 shares owned by VHCP Co-Investment Holdings, LLC, 298,846 shares owned by Venrock Healthcare Capital Partners II, L.P. and 121,154 shares owned by VHCP Co-Investment Holdings II, LLC. |
3 | This percentage is calculated based upon 18,253,456 shares of the Issuer’s common stock outstanding as of November 11, 2015, as set forth in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2015. |
CUSIP No. 53630X104 | Page 7 of 16 |
| | | | | |
1. | | Name of reporting persons VHCP Management II, LLC |
2. | | Check the appropriate box if a member of a group (see instructions) (a) x1 (b) ¨ |
3. | | SEC use only |
4. | | Citizenship or place of organization Delaware |
Number of shares beneficially owned by each reporting person with: | 5. | | Sole voting power 0 |
6. | | Shared voting power 1,269,9212 |
7. | | Sole dispositive power 0 |
8. | | Shared dispositive power 1,269,9212 |
9. | | Aggregate amount beneficially owned by each reporting person 1,269,9212 |
10. | | Check if the aggregate amount in Row (9) excludes certain shares (see instructions) ¨ |
11. | | Percent of class represented by amount in Row (9) 7.0%3 |
12. | | Type of reporting person (see instructions) OO |
1 | Venrock Healthcare Capital Partners, L.P., VHCP Co-Investment Holdings, LLC, Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management, LLC, VHCP Management II, LLC, Bong Koh and Anders Hove are members of a group for the purposes of this Schedule 13G/A. |
2 | Consists of 718,490 shares owned by Venrock Healthcare Capital Partners, L.P., 131,431 shares owned by VHCP Co-Investment Holdings, LLC, 298,846 shares owned by Venrock Healthcare Capital Partners II, L.P. and 121,154 shares owned by VHCP Co-Investment Holdings II, LLC. |
3 | This percentage is calculated based upon 18,253,456 shares of the Issuer’s common stock outstanding as of November 11, 2015, as set forth in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2015. |
CUSIP No. 53630X104 | Page 8 of 16 |
| | | | | |
1. | | Name of Reporting Persons Hove, Anders |
2. | | Check the Appropriate Box if a Member of a Group (See Instructions) (a) x1 (b) ¨ |
3. | | SEC USE ONLY |
4. | | Citizenship or Place of Organization United States |
Number of Shares Beneficially Owned by Each Reporting Person With: | 5. | | Sole Voting Power 0 |
6. | | Shared Voting Power 1,269,9212 |
7. | | Sole Dispositive Power 0 |
8. | | Shared Dispositive Power 1,269,9212 |
9. | | Aggregate Amount Beneficially Owned by Each Reporting Person 1,269,9212 |
10. | | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨ |
11. | | Percent of Class Represented by Amount in Row (9) 7.0%3 |
12. | | Type of Reporting Person (See Instructions) IN |
1 | Venrock Healthcare Capital Partners, L.P., VHCP Co-Investment Holdings, LLC, Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management, LLC, VHCP Management II, LLC, Bong Koh and Anders Hove are members of a group for the purposes of this Schedule 13G/A. |
2 | Consists of 718,490 shares owned by Venrock Healthcare Capital Partners, L.P., 131,431 shares owned by VHCP Co-Investment Holdings, LLC, 298,846 shares owned by Venrock Healthcare Capital Partners II, L.P. and 121,154 shares owned by VHCP Co-Investment Holdings II, LLC. |
3 | This percentage is calculated based upon 18,253,456 shares of the Issuer’s common stock outstanding as of November 11, 2015, as set forth in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2015. |
CUSIP No. 53630X104 | Page 9 of 16 |
| | | | | |
1. | | Name of Reporting Persons Koh, Bong |
2. | | Check the Appropriate Box if a Member of a Group (See Instructions) (a) x1 (b) ¨ |
3. | | SEC USE ONLY |
4. | | Citizenship or Place of Organization United States |
Number of Shares Beneficially Owned by Each Reporting Person With: | 5. | | Sole Voting Power 0 |
6. | | Shared Voting Power 1,269,9212 |
7. | | Sole Dispositive Power 0 |
8. | | Shared Dispositive Power 1,269,9212 |
9. | | Aggregate Amount Beneficially Owned by Each Reporting Person 1,269,9212 |
10. | | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨ |
11. | | Percent of Class Represented by Amount in Row (9) 7.0%3 |
12. | | Type of Reporting Person (See Instructions) IN |
1 | Venrock Healthcare Capital Partners, L.P., VHCP Co-Investment Holdings, LLC, Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management, LLC, VHCP Management II, LLC, Bong Koh and Anders Hove are members of a group for the purposes of this Schedule 13G/A. |
2 | Consists of 718,490 shares owned by Venrock Healthcare Capital Partners, L.P., 131,431 shares owned by VHCP Co-Investment Holdings, LLC, 298,846 shares owned by Venrock Healthcare Capital Partners II, L.P. and 121,154 shares owned by VHCP Co-Investment Holdings II, LLC. |
3 | This percentage is calculated based upon 18,253,456 shares of the Issuer’s common stock outstanding as of November 11, 2015, as set forth in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2015. |
CUSIP No. 53630X104 | Page 10 of 16 |
Introductory Note: This Schedule 13G/A is filed on behalf of Venrock Healthcare Capital Partners, L.P., a limited partnership organized under the laws of the State of Delaware (“VHCP LP”), VHCP Co-Investment Holdings, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Co-Investment”), Venrock Healthcare Capital Partners II, L.P., a limited partnership organized under the laws of the State of Delaware (“VHCP II LP”), VHCP Co-Investment Holdings II, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Co-Investment II”), VHCP Management, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Management”), VHCP Management II, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Management II” and collectively with VHCP LP, VHCP II LP, VHCP Co-Investment II, VHCP Management and VHCP Co-Investment, the “Venrock Entities”), Anders Hove (“Hove”) and Bong Koh (“Koh”) in respect of Common Stock of Lipocine Inc.
Item 1.
Lipocine Inc.
| (b) | Address of Issuer’s Principal Executive Offices |
675 Arapeen Drive
Suite 202
Salt Lake City, Utah 84108
Item 2.
Venrock Healthcare Capital Partners, L.P.
VHCP Co-Investment Holdings, LLC
Venrock Healthcare Capital Partners II, L.P.
VHCP Co-Investment Holdings II, LLC
VHCP Management, LLC
VHCP Management II, LLC
Anders Hove
Bong Koh
| (b) | Address of Principal Business Office or, if none, Residence |
| | | | |
New York Office: | | Palo Alto Office: | | Boston Office: |
| | |
530 Fifth Avenue | | 3340 Hillview Avenue | | 470 Atlantic Avenue |
| | |
22nd Floor | | Palo Alto, CA 94304 | | 4th Floor |
| | |
New York, NY 10036 | | | | Boston, MA 02210 |
All entities were organized in Delaware. The individuals are both United States citizens.
| (d) | Title of Class of Securities |
Common Stock
53630X104
CUSIP No. 53630X104 | Page 11 of 16 |
Item 3. | If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a: |
Not applicable
| (a) | Amount Beneficially Owned as of December 31, 2015: |
| | | | |
Venrock Healthcare Capital Partners, L.P. | | | | |
VHCP Co-Investment Holdings, LLC | | | 1,269,921 | (1) |
Venrock Healthcare Capital Partners II, L.P. | | | | |
VHCP Co-Investment Holdings II, LLC | | | 1,269,921 | (1) |
| | | | |
VHCP Management II, LLC | | | 1,269,921 | (1) |
| | | | |
Bong Koh | | | 1,269,921 | (1) |
| (b) | Percent of Class as of December 31, 2015: |
| | | | |
Venrock Healthcare Capital Partners, L.P. | | | | |
VHCP Co-Investment Holdings, LLC | | | | |
Venrock Healthcare Capital Partners II, L.P. | | | | |
VHCP Co-Investment Holdings II, LLC | | | | |
| | | | |
VHCP Management II, LLC | | | | |
| | | | |
Bong Koh | | | | |
| (c) | Number of shares as to which the person has, as of December 31, 2015: |
| (i) | Sole power to vote or to direct the vote |
| | | |
Venrock Healthcare Capital Partners, L.P. | | | |
VHCP Co-Investment Holdings, LLC | | | 0 |
Venrock Healthcare Capital Partners II, L.P. | | | |
VHCP Co-Investment Holdings II, LLC | | | 0 |
| | | |
VHCP Management II, LLC | | | 0 |
| | | |
Bong Koh | | | 0 |
CUSIP No. 53630X104 | Page 12 of 16 |
| (ii) | Shared power to vote or to direct the vote |
| | | | |
Venrock Healthcare Capital Partners, L.P. | | | | |
VHCP Co-Investment Holdings, LLC | | | 1,269,921 | (1) |
Venrock Healthcare Capital Partners II, L.P. | | | | |
VHCP Co-Investment Holdings II, LLC | | | 1,269,921 | (1) |
| | | | |
VHCP Management II, LLC | | | 1,269,921 | (1) |
| | | | |
Bong Koh | | | 1,269,921 | (1) |
| (iii) | Sole power to dispose or to direct the disposition of |
| | | |
Venrock Healthcare Capital Partners, L.P. | | | |
VHCP Co-Investment Holdings, LLC | | | 0 |
Venrock Healthcare Capital Partners II, L.P. | | | |
VHCP Co-Investment Holdings II, LLC | | | 0 |
| | | |
VHCP Management II, LLC | | | 0 |
| | | |
Bong Koh | | | 0 |
| (iv) | Shared power to dispose or to direct the disposition of |
| | | | |
Venrock Healthcare Capital Partners, L.P. | | | | |
VHCP Co-Investment Holdings, LLC | | | 1,269,921 | (1) |
Venrock Healthcare Capital Partners II, L.P. | | | | |
VHCP Co-Investment Holdings II, LLC | | | 1,269,921 | (1) |
| | | | |
VHCP Management II, LLC | | | 1,269,921 | (1) |
| | | | |
Bong Koh | | | 1,269,921 | (1) |
(1) | These shares are owned directly as follows: 718,490 shares are owned by Venrock Healthcare Capital Partners, L.P., 131,431 shares are owned by VHCP Co-Investment Holdings, LLC, 298,846 shares are owned by Venrock Healthcare Capital Partners II, L.P. and 121,154 shares are owned by VHCP Co-Investment Holdings II, LLC. VHCP Management, LLC is the general partner of Venrock Healthcare Capital Partners, L.P. and the manager of VHCP Co-Investment Holdings, LLC. VHCP Management II, LLC is the general partner of Venrock Healthcare Capital Partners II, L.P. and the manager of VHCP Co-Investment Holdings II, LLC. Messrs. Hove and Koh are the managing members of VHCP Management, LLC and VHCP Management II, LLC. |
Item 5. | Ownership of Five Percent or Less of a Class |
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ¨.
Item 6. | Ownership of More than Five Percent on Behalf of Another Person |
Not Applicable
CUSIP No. 53630X104 | Page 13 of 16 |
Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person. |
Not Applicable
Item 8. | Identification and Classification of Members of the Group |
Not Applicable
Item 9. | Notice of Dissolution of a Group |
Not Applicable
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
CUSIP No. 53630X104 | Page 14 of 16 |
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: February 16, 2016
| | | | | | | | | | | | |
Venrock Healthcare Capital Partners, L.P. | | | | VHCP Co-Investment Holdings, LLC |
| | | | |
By: | | VHCP Management, LLC, | | | | By: | | VHCP Management, LLC, |
| | |
| | its General Partner | | its Manager |
| | | | |
By: | | | | | | By: | | |
| | Name: | | David L. Stepp | | | | | | Name: | | David L. Stepp |
| | | | | | |
| | Title: | | Authorized Signatory | | | | | | Title: | | Authorized Signatory |
| | | | |
VHCP Management, LLC | | | | | | | | |
| | | | | |
By: | | | | | | | | | | |
| | Name: | | David L. Stepp | | | | | | | | |
| | | | | | |
| | Title: | | Authorized Signatory | | | | | | | | |
| | | | |
/s/ David L. Stepp, as attorney-in-fact | | | | | | | | |
| | | | |
Anders Hove | | | | | | | | |
| | | | |
/s/ David L. Stepp, as attorney-in-fact | | | | | | | | |
| | | | |
Bong Koh | | | | | | | | |
| | | | | | | | | | | | |
Venrock Healthcare Capital Partners II, L.P. | | | | VHCP Co-Investment Holdings II, LLC |
| | | | |
By: | | VHCP Management II, LLC, | | | | By: | | VHCP Management II, LLC, |
| | |
| | its General Partner | | its Manager |
| | | | |
By: | | | | | | By: | | |
| | Name: | | David L. Stepp | | | | | | Name: | | David L. Stepp |
| | | | | | |
| | Title: | | Authorized Signatory | | | | | | Title: | | Authorized Signatory |
| | | | |
CUSIP No. 53630X104 | Page 15 of 16 |
VHCP Management II, LLC | | | | | | | | |
| | | | | |
By: | | | | | | | | | | |
| | Name: | | David L. Stepp | | | | | | | | |
| | | | | | |
| | Title: | | Authorized Signatory | | | | | | | | |
CUSIP No. 53630X104 | Page 16 of 16 |
EXHIBITS
A: | Joint Filing Agreement (Incorporated by reference from Exhibit A to Schedule 13G filed on February 13, 2015) |
B: | Power of Attorney for Anders Hove (Incorporated by reference from Exhibit B to Schedule 13G filed on February 13, 2015) |
C: | Power of Attorney for Bong Koh (Incorporated by reference from Exhibit C to Schedule 13G filed on February 13, 2015) |